Relapse/Refractory Multiple Myeloma

Explore clinical trials studying Relapse/Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapse/Refractory Multiple Myeloma trial results

Recruiting

NCT06084962

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

Completed

NCT03944057

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China

Nanfang Hospital Guangzhou, Guangdong, China

View all 17 locations

Completed

NCT03353545

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Ag.Andreas General Hospital Pátrai, Greece

Completed

NCT02290431

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Kashiwa, Chiba, Japan

Novartis Investigative Site Matsuyama, Ehime, Japan

Novartis Investigative Site Fukuoka, Japan

View all 20 locations

Active, Not Recruiting

NCT04613557

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: H. Lee Moffitt Cancer Center Tampa, Florida, United States

Nyu Langone Hospitals New York, United States

Universitair Ziekenhuis Antwerpen Antwerp, Belgium

Institut Jules Bordet Brussels, Belgium